Agenda: The 17th Canada-EU Biotech Market Access Issues Dialogue

December 17, 2025 (by videoconference)

Agenda

1. Introductions and opening remarks
   Canadian Co-Chair
   European Union (EU) Co-Chair
2. Genetically modified (GM) event approvals: European Food Safety Authority (EFSA) assessment and timelines (Canada)
   1. 2.1. Status of specific applications under EFSA assessment/post-EFSA approval
   2. 2.2. Pre and post EFSA assessment process and timelines
   3. 2.3. GM Authorization Renewals for Food & Feed
3. EU stacked GM event approval process (Canada)
4. EU’s New Genomic Techniques (NGTs) regulation (Canada)
   1. 4.1. Update on New Genomic Techniques regulation proposal (EU)
5. Status of Canada’s proposal to terminate Triffid Testing Protocol on Flaxseed Exports to the EU (Canada)
6. EU’s new proposed Biotech Act (Canada)
   1. 6.1. Canada requesting EU to provide regulatory overview of new proposed Biotech Act (EU)
7. Closing remarks and next steps
   Canadian Co-Chair
   EU Co-Chair